The ruling is part of a series of legal battles inherited by Bayer following its acquisition of Monsanto in 2018, including lawsuits alleging Roundup’s cancer-causing properties. Financially ...

Bayer CEO Bill Anderson’s team insisted I watch an hour-long presentation, hosted by Anderson, on Dynamic Shared Ownership ...

Bayer AG’s Monsanto unit stopped making toxic PCBs a half century ago, but the legal fallout lingers even as many of the building materials made with the chemicals are no longer used in US homes ...

Concerns about a repeat of disasters like AOL-Time Warner or Bayer-Monsanto immediately spring ... augur a resurgence of chunky M&A. When acquisitions reach $10 billion or more, however, the ...

Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on January 21 and set a price target of ...

A new trend is emerging among corporations to seek immunity from prosecution and prevent consumers from suing after the corporation’s product injures a consumer. As an example, Bayer/Monsanto 1 ...

(Bloomberg) -- Bayer AG plans to push pause on some of its pharmaceutical dealmaking, focusing instead on reducing the high debt load the company still faces after its $63 billion acquisition of ...

Berenberg Bank analyst Sebastian Bray maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €22.00. The ...

The verdict in a California state court in Oakland was the third courtroom defeat for Bayer in cases accusing the chemicals in Roundup of causing cancer. Glyphosate developer Monsanto was ...

Bayer’s Monsanto unit stopped making toxic polychlorinated ... which have lost about 80 per cent of their value since the acquisition. The company has reserved US$16 billion for US lawsuits ...

Bayer CEO Bill Anderson’s team insisted ... Anderson believes the Monsanto acquisition was strategically brilliant, even if financially flawed. I asked why he was reinventing the organization ...